Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Regulatory News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Varithena® Receives Finalised Category I CPT Codes

6 Nov 2017 07:00

RNS Number : 5907V
BTG PLC
06 November 2017
 

BTG plc: Varithena® receives finalised category I CPT codes

New payment rates and automatic electronic processing of claims effective 1 January 2018

 

London, UK, 6 November 2017: BTG plc (LSE: BTG), the global specialist healthcare company, notes that the US Centers for Medicare and Medicaid Services have published the final fee schedule for new Category I CPT codes for Varithena® procedures. The codes will be effective from 1 January 2018.

 

The fee schedule details payments for conducting Varithena® treatments in the physician office setting of $1,624.30 for a single vein and $1,697.02 for multiple veins. The new CPT codes define Medicare payment rates and enable automatic and electronic processing of claims, providing physicians in the US with further predictability of payment and streamlining the reimbursement process.

 

"We believe the new CPT codes are appropriate and have the potential to underpin our current expectations for the product," commented Louise Makin, BTG's CEO. "However, we must wait and see how they impact physician adoption and insurer practices, and we should have a better understanding of that by the end of 2018."

 

For further information contact

BTG

Andy Burrows, VP Corporate & Investor Relations

+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605

 

Stuart Hunt, Investor Relations Manager

+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536

 

Chris Sampson, Corporate Communications Director

+44 (0)20 7575 1595; Mobile: +44 (0)7773 251 178

 

FTI Consulting

Ben Atwell/Simon Conway

+44 (0)20 3727 1000

 

About BTG

BTG is a global specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of cancer, severe emphysema, severe blood clots and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges. To learn more about BTG, please visit: btgplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMMGMGKRGNZZ
Date   Source Headline
19th Aug 20193:24 pmRNSForm 8.3 - BTG plc
19th Aug 20193:20 pmRNSForm 8.3 - BTG plc
19th Aug 20193:04 pmRNSForm 8.3 - BTG Plc
19th Aug 201911:00 amRNSForm 8.5 (EPT/RI)
19th Aug 201910:33 amBUSForm 8.5 (EPT/NON-RI) - BTG PLC
19th Aug 201910:28 amRNSForm 8.5 (EPT/RI) - BTG plc
19th Aug 201910:22 amRNSForm 8.5 (EPT/RI) BTG plc
19th Aug 20199:21 amRNSScheme becomes Effective
19th Aug 20197:30 amRNSTemporary Suspension BTG PLC
16th Aug 20193:40 pmRNSDirector/PDMR Shareholding
16th Aug 20193:20 pmRNSForm 8.3 - BTG plc
16th Aug 20192:57 pmRNSForm 8.3 - BTG plc
16th Aug 20192:01 pmEQSForm 8.3 - The Vanguard Group, Inc.: BTG plc
16th Aug 201911:40 amBUSForm 8.5 (EPT/NON-RI) - BTG PLC
16th Aug 201911:05 amRNSForm 8.5 (EPT/RI) - BTG plc
16th Aug 201911:01 amRNSForm 8.5 (EPT/RI)
16th Aug 201910:41 amRNSForm 8.5 (EPT/RI) BTG plc
15th Aug 20195:27 pmRNSHolding(s) in Company
15th Aug 20193:23 pmRNSCourt sanction of the Scheme
15th Aug 20193:20 pmRNSForm 8.3 - BTG plc
15th Aug 20193:16 pmRNSForm 8.3 - BTG plc
15th Aug 20192:40 pmRNSForm 8.3 - BTG plc
15th Aug 201911:16 amRNSForm 8.5 (EPT/RI)
15th Aug 201911:04 amRNSForm 8.5 (EPT/RI) - BTG plc
15th Aug 201910:57 amBUSFORM 8.5 (EPT/NON-RI) - BTG PLC
15th Aug 20199:59 amRNSForm 8.5 (EPT/RI) BTG plc
14th Aug 20195:30 pmRNSBTG
14th Aug 20195:11 pmRNSHolding(s) in Company
14th Aug 20193:20 pmRNSForm 8.3 - BTG plc
14th Aug 20192:59 pmRNSForm 8.3 - BTG Plc
14th Aug 20192:58 pmBUSForm 8.5 (EPT/NON-RI) - BTG PLC
14th Aug 201912:09 pmBUSForm 8.5 (EPT/NON-RI) - BTG PLC - Amendment
14th Aug 201911:50 amRNSForm 8.5 (EPT/RI) - BTG plc
14th Aug 201911:02 amRNSForm 8.5 (EPT/RI)
14th Aug 201910:45 amRNSForm 8.3 - BTG plc
14th Aug 201910:07 amRNSForm 8.5 (EPT/RI) BTG plc
13th Aug 20195:22 pmRNSHolding(s) in Company
13th Aug 20193:20 pmRNSForm 8.3 - BTG plc
13th Aug 20193:00 pmRNSForm 8.3 - BTG Plc
13th Aug 20192:51 pmRNSForm 8.3 - BTG plc
13th Aug 20192:37 pmEQSForm 8.3 - The Vanguard Group, Inc.: BTG plc
13th Aug 201912:58 pmBUSForm 8.3 - BTG PLC
13th Aug 201912:57 pmBUSForm 8.3 - BTG PLC - Amendment
13th Aug 201911:39 amBUSForm 8.5 (EPT/NON-RI) - BTG PLC
13th Aug 201911:03 amRNSForm 8.5 (EPT/RI)
13th Aug 201910:06 amRNSForm 8.5 (EPT/RI)- BTG plc
13th Aug 20199:51 amRNSForm 8.5 (EPT/RI) BTG plc
13th Aug 20199:41 amRNSForm 8.3 - BTG plc
12th Aug 20195:30 pmRNSBTG
12th Aug 20193:52 pmBUSForm 8.5 (EPT/NON-RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.